Related Experiment Videos
Intra-abdominal desmoplastic small round cell tumour
J R Miliauskas1, R L Abbott, R Sarre
1Gribbles Pathology, Adelaide, Australia.
The Australian and New Zealand Journal of Surgery
|February 1, 1993
Summary
Desmoplastic small round cell tumors are rare and aggressive intra-abdominal cancers. This case highlights the poor prognosis and rapid relapse even after aggressive multimodal treatment in a young male patient.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Desmoplastic small round cell tumor (DSRCT) is a rare and aggressive malignancy.
- DSRCT exhibits a unique combination of epithelial, mesenchymal, and neural differentiation.
- The clinical course of DSRCT is typically aggressive, with a poor prognosis.
Observation:
- A 15-year-old male presented with intra-abdominal desmoplastic small round cell tumor.
- The patient underwent debulking surgery and chemotherapy.
- Disease relapse occurred 1 month post-initial treatment.
Findings:
- Despite further debulking surgery, extensive chemotherapy, and bone marrow transplantation, the patient experienced a second relapse 5 months later.
- The patient's total survival was limited to 20 months.
- This case underscores the aggressive nature and limited treatment efficacy for DSRCT.
Implications:
- Aggressive multimodal therapy, including surgery, chemotherapy, and bone marrow transplantation, offers limited long-term survival for DSRCT.
- Further research is needed to identify more effective therapeutic strategies for desmoplastic small round cell tumors.
- Understanding the unique biological features of DSRCT may lead to novel targeted treatments.